Open AccessThe use of atosiban and ritodrine in external cephalic version
Author(s) -
STERGIOTOU IOSIFINA,
TALBOT FLEUR,
YOONG WAI
Publication year - 2007
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1080/00016340701343123
Subject(s) - ritodrine , medicine , external cephalic version , tocolytic agent , tocolytic , obstetrics , preterm labour , adverse effect , anesthesia , pregnancy , fetus , preterm labor , gestation , breech presentation , genetics , biology
Objective . To compare the efficacy of atosiban and ritodrine as tocolytic agents for successful external cephalic version (ECV). Factors affecting the success of ECV, as well as maternal and perinatal outcomes are reviewed. Method . A retrospective review of women who underwent ECV with either atosiban (2004) or ritodrine (2002). Results . Atosiban and ritodrine were similarly effective (28 versus 41%, p >0.05). Side effects were more common with ritodrine. No significant adverse maternal and perinatal outcomes were recorded following procedures with either tocolytic. Conclusion . Atosiban is a safe choice for ECV with less maternal side effects. However, it is no more effective than ritodrine and the benefit of safety has to be balanced against that of cost.